|Articles|January 20, 2023
T Cell expansion in the DASbox® Mini Bioreactor System
Author(s)Eppendorf
This application note examines the suitability of BioBLU® 0.3c Single-Use Bioreactors and the DASbox Mini Bioreactor System in the long-term expansion of CD4+ T cells.
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Related Content
Trending on BioPharm International
1
A-TEEM: A Novel, Powerful Tool for Evaluating and Monitoring Cell Culture Media
2
From Parm to Pharm: Avantor, p-Chip Bring COI Compliance to Clinical Consumables
3
Challenges, Innovations, and Future Outlook of Biologics Formulations
4
Global Study Confirms Survival Advantage of Mogamulizumab in Advanced Mycosis Fungoides and Sézary Syndrome
5
